Wiersinga W M, Prummel M F
Department of Medicine, University of Amsterdam, The Netherlands.
Endocrinol Metab Clin North Am. 2000 Jun;29(2):297-319, vi-vii. doi: 10.1016/s0889-8529(05)70133-x.
A recent survey demonstrated considerable controversy about the therapeutic approach to a patient with Graves' ophthalmopathy. Among various reasons for this disagreement is the lack of an accepted way to assess the outcome of a given therapeutic intervention. An evidence-based approach requires an objective and meaningful assessment of therapeutic outcomes in prospective, randomized studies in which confounding factors (e.g., smoking, disease activity, and state of the thyroid) are accounted for and controlled. On the basis of the available studies, a treatment approach can be selected.
最近的一项调查表明,对于格雷夫斯眼病患者的治疗方法存在相当大的争议。这种分歧的各种原因之一是缺乏一种公认的方法来评估特定治疗干预的结果。基于证据的方法需要在前瞻性、随机研究中对治疗结果进行客观且有意义的评估,在这些研究中,混杂因素(如吸烟、疾病活动度和甲状腺状态)要得到考虑和控制。根据现有研究,可以选择一种治疗方法。